Combining DNA methyltransferase and histone deacetylase inhibition to treat acute myeloid leukemia/myelodysplastic syndrome: Achievements and challenges

Author： Lübbert Michael   Kuendgen Andrea  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|4|498-501

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.4, 2015-02, pp. : 498-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Six (or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

By Gore Steven D.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 1, 2006-01 ,pp. : 83-90

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor

By  

Current Cancer Drug Targets, Vol. 15, Iss. 6, 2015-01 ,pp. : 493-503

Bentham Science Publishers

Access to resources Recommend Favorite

Suppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib

By Epling-Burnette Pearlie K   Loughran Jr Thomas P  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 689-698

Informa Healthcare

Access to resources Recommend Favorite

DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences

By Thomas Xavier  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 11, 2012-11 ,pp. : 1039-1051

Informa Healthcare

Access to resources Recommend Favorite

Targeting Epigenetics through Histone Deacetylase Inhibitors in Acute Lymphoblastic Leukemia

By  

Current Cancer Drug Targets, Vol. 11, Iss. 7, 2011-09 ,pp. : 882-893

Bentham Science Publishers

Access to resources Recommend Favorite